Financial Summary (All financials)
| In millions, except per share items | Oct-29-17 | Oct-30-16 | Nov-01-15 | Nov-02-14 |
| Revenues | 17,636 | 13,240 | 6,824 | 4,269 |
| Revenue growth | 33.2% | 94.0% | 59.9% | |
| Cost of goods sold | 9,127 | 7,300 | 3,271 | 2,392 |
| Gross profit | 8,509 | 5,940 | 3,553 | 1,877 |
| Gross margin | 48.2% | 44.9% | 52.1% | 44.0% |
| Selling, general and administrative | 787 | 806 | 486 | 407 |
| Research and development | 3,292 | 2,674 | 1,049 | 695 |
| EBITA | 4,449 | 2,517 | 2,025 | 797 |
| EBITA margin | 25.2% | 19.0% | 29.7% | 18.7% |
| Amortization of intangibles | 1,764 | 1,873 | 249 | 197 |
| EBIT | 2,685 | 644 | 1,776 | 600 |
| EBIT margin | 15.2% | 4.9% | 26.0% | 14.1% |
| Pre-tax income | 1,825 | -1,107 | 1,467 | 342 |
| Income taxes | 35 | 642 | 76 | 33 |
| Tax rate | 1.9% | | 5.2% | 9.6% |
| Earnings from continuing ops | 3,488 | -1,627 | 2,782 | 618 |
| Earnings from discontinued ops | -6 | -112 | -27 | -46 |
| Net income | 3,482 | -1,739 | 2,755 | 572 |
| Net margin | 19.7% | -13.1% | 40.4% | 13.4% |
| |
| Diluted EPS | $8.29 | ($4.25) | $9.90 | $2.31 |
| Shares outstanding (diluted) | 421 | 383 | 281 | 267 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|